Waterland Private Equity invests in imc group

Clearwater International’s debt advisory team has advised Waterland Private Equity (Waterland) on raising debt finance from LGT Capital Partners to support the acquisition of integrated medhealth communication group (imc), Barclays Bank have provided working capital facilities.

Established in 2006, imc provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device and diagnostic companies globally. This includes 8 of the 20 largest drug companies in the world such as AstraZeneca and Takeda. imc’s service offering includes medical communication, interactive digital and virtual, creative marketing, customer insights and patient engagement; collectively, these are aimed at enriching the lives of patients through human centric programmes that inform decisions to improve health. imc has offices in London, Cambridge (UK), Toronto, Boston and Cairo and a highly qualified employee base of 100 people.

imc’s underlying markets are expected to grow at circa 9 per cent pa as an ageing population boosts demand for new drug treatments and R&D investment is supported by increasing regulation and outsourcing. This in turn is boosting demand for effective healthcare communications.

The investment from Waterland will enable imc to expand its global footprint through a buy-and-build strategy with significant follow-on funding available to acquire and build out communications, digital and consulting agencies across the UK, North America and EMEA. The investment will also be used to add further capabilities and service offerings, further enhancing the group’s existing digital and technology capabilities.


More:  David Ball, the former owner and CEO of Bridge Farm and current partner at Artemis Growth Partners, acquire the business from Sundial Growers

More from: | Category: M&A News